KEDANSIL

Class [005]
Pharmaceutical preparations for use in oncology; pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, metabolic, respiratory, nervous, neurological, and gastrointestinal systems; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for the treatment of infection, namely anti-invective, and for the treatment of inflammation, namely anti-inflammatories; pharmaceutical preparations and substances, namely antibodies for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, antibodies for use in gastroenterology, antibodies for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, obesity and hypothyroidism, antibodies for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases, antibodies for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances, namely therapeutic vaccines for humans for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, therapeutic vaccines for humans for use in gastroenterology, therapeutic vaccines for humans for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, obesity and hypothyroidism, therapeutic vaccines for humans for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases, therapeutic vaccines for humans for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies.